Daily newsletter, 19 Nov 2026

MICROREGISTRAR · INFECTION INTELLIGENCE
Prepared for microregistrar.com, microregistrar.moodlecloud.com and Infection Institute

Thursday 19 November 2026

MICROREGISTRAR · INFECTION INTELLIGENCE — Daily Infection Update

This summary is an AI-assisted aggregation of published sources. Always read the original article via the link before acting on anything here. For academic use only, not clinical advice.

01 Executive Summary

  1. Confirmed Defra/APHA · HPAI H5N1 · 18 Nov

    1 Two more HPAI H5N1 outbreaks in English commercial poultry: near Coningsby, Lincolnshire (AIV 2026/30) and near Thirsk, North Yorkshire (AIV 2026/31)

    Both were confirmed on 18 Nov. 3 km protection and 10 km surveillance zones were declared around each premises, and all poultry on site will be culled. These are the first new GB poultry cases since Belford (13 Nov). The Northern Ireland AIPZ, with mandatory housing, took effect at 00:01 today (DAERA, announced 16 Nov).

    Detail not yet published: the case notices give no flock type or size, and we did not open the declaration PDFs. Neither notice states any human exposure or UKHSA follow-up.

    Coningsby case notice › · Thirsk case notice ›

  2. Confirmed ECDC · CRE · 18 Nov

    2 ECDC CRE rapid risk assessment (fourth update): very high risk to patients in EU/EEA healthcare, driven by NDM and OXA-244

    The CRE25 survey and EURGen-Net show a growing share of NDM carbapenemases in K. pneumoniae, more acquisition of the virulence factors yersiniabactin and aerobactin, and spread of E. coli carrying blaOXA-244. NDM is eroding the new beta-lactam/beta-lactamase inhibitor options. ECDC rates the probability of further spread in healthcare and community settings as high. Its recommendations: national CRE strategies, IPC (hand hygiene, screening, contact precautions), rapid carbapenemase detection, near-real-time WGS, stewardship, and access to agents active against NDM producers.

    Read from the ECDC summary page only: the full PDF (fourth update) and CRE25 survey figures were not opened. No UK data are included; UK applicability is by analogy only.

    ECDC rapid risk assessment ›

  3. Confirmed WHO · Ebola (Bundibugyo) · 17 Nov

    3 WHO Director-General to the third IHR Emergency Committee: DRC Bundibugyo cases have more than doubled in three months

    The published remarks give more than 11,000 cases and 5,400 deaths in 67 health zones across eight provinces. Children account for more than a quarter of confirmed cases and a third of deaths; seven in ten confirmed children under five have died. Kenya has nine linked cases, including two deaths, and its 42-day countdown has begun. Nigeria has one imported case. Two Bundibugyo-specific candidate vaccines will join the Ervebo trial in the coming weeks.

    Inconsistent figures: the published WHO remarks say “more than 11 000 cases and 5400 deaths” in 67 health zones across eight provinces. CIDRAP reports the Director-General giving 11,536 confirmed cases and 5,635 confirmed deaths, figures that are not in the published text. Yesterday’s issue had ECDC 11,376 (16 Nov) and CDC via CIDRAP 11,463 cases. The Emergency Committee’s statement and any change to temporary recommendations had not been published by the cut-off. Use the WHO wording.

    WHO DG remarks ›

  4. Confirmed PAHO · AMR · 18 Nov

    4 PAHO: carbapenem resistance in K. pneumoniae in Latin America and the Caribbean rose from about 15% (2015) to 26% (2024)

    E. coli rose from 3% to 5%. Median carbapenem resistance in A. baumannii was 77% in 2024 (seven reporting countries). Data come from the ReLAVRA+ network.

    Regional medians: the figures come from ReLAVRA+ data reported by 15 countries (K. pneumoniae), 13 (E. coli) and 7 (A. baumannii), so they may not represent the whole region.

    PAHO news release ›

Microregistrar Moodle update

Today’s update

Read directly from the MoodleCloud Google Sheet Index tab (“Whats new?” column) through the Google connector on the morning of 19 Nov.

2 new rows since the 18 Nov issue (both added 18 Nov): HYN interactive – CMV serology and HYN interactive – EBV serology. Both are linked in the Latest 10 below.

Sheet ›

Latest 10 on Microregistrar Moodle

The 10 most recently added items from the Index tab (“Whats new?”), newest first. Each button opens the item on Moodle.

Content list

What is Microregistrar Moodle

Microregistrar.moodlecloud.com is an online learning platform for doctors preparing for the FRCPath Medical Microbiology examinations. It provides structured revision support for Part 1 and Part 2, including core microbiology topics, high-yield notes, exam-focused questions, guideline and UKHSA updates, laboratory interpretation material, and practical study guidance.

The same page says it includes material curated and written by experienced UK microbiologists; interactive high-yield notes; regular updates on guidelines and important studies; updates from the Health Protection Report; guidance for Part 1 and Part 2; an active members-only WhatsApp group; approximately 500 FRCPath Part 1-style MCQs with answers and explanations; more than 100 Part 2 questions with model answers; and a standing Part 2 mock examination. It also states that the group at present has >400 members from various parts of the world and, over the last 3 years, has supported >700 members. Approved members can access course materials after enrolment.

Wording taken from microregistrar.com/microregistrar-moodle-frcpath/ (checked 16 Nov 2026; fees unchanged). The Moodle front page itself returned 403 to our fetch, so it was not used as a source.

How to subscribe / join

The public Moodle page on microregistrar.com is headed “How to register for Moodle?” It states: “Access to Microregistrar is by application. Applicants are reviewed to ensure the platform remains focused on postgraduate medical training.” The application process, as printed, is:

  1. Fill in this form: https://docs.google.com/forms/d/e/1FAIpQLSce6cMaQ5BEU3iMOBm4cJakNMtKiGYnSONVlEjZa_WXTkNCWQ/viewform
  2. Send an email that you have filled in the application form to microregistrar@gmail.com
  3. “I shall send you more information, the payment link, and further instructions.”

Membership fee (as printed on that page): 6 months – £58.5; 1 year – £99.0. “There is no autorenewal. If you want to renew, follow the above process and contact me.”

Taken from microregistrar.com/microregistrar-moodle-frcpath/ (checked 16 Nov 2026; fees unchanged). moodlecloud.com/login/signup.php and the Moodle front page returned 403 to our fetch, so we could not verify whether a signup form on the Moodle site itself matches this process.

02 UK Infection Updates

UKHSA, the UKHSA dashboard, NHS England, PHS, PHW, NI PHA, Ireland HPSC, NICE and national events.

Confirmed UKHSA · Cold-health alert

Yellow cold-health alerts extended to 09:00 on Monday 23 November (North West, North East, Yorkshire and the Humber)

Updated on 18 Nov. All other regions of England are unaffected. Yellow alerts flag risk to vulnerable people, including those aged 65 and over and people with respiratory or cardiovascular disease. Plan for winter pressures accordingly.

UKHSA news story ›

The HPAI poultry cases are under 07 One Health. UKHSA also added its SFTS contact-tracing guidance to the SFTS overview and VHF collection pages (18 Nov). That guidance was covered yesterday and this is not a material change. No other UKHSA infection item in the window. NHS England, PHS, PHW, NI PHA, HPSC and NICE were not checked this morning (see Gaps).

UKHSA SFTS overview › · UKHSA dashboard ›

03 Global Outbreaks

WHO DON, ECDC, CDC, WHO AFRO, PAHO and WHO SEARO. Only items with a material development in the window are written up.

Confirmed WHO · Bundibugyo virus disease · DRC

Third IHR Emergency Committee meeting: WHO Director-General’s opening remarks (17 Nov)

Six months after the outbreak was declared, WHO reports more than 11,000 cases and 5,400 deaths in 67 health zones across eight provinces. Cases have more than doubled since the Committee last met three months ago. Children account for more than a quarter of confirmed cases and a third of deaths, and seven in ten confirmed children under five have died. Kenya: nine cases linked to an import, including two deaths; the last patient has been discharged and the 42-day countdown is running. Nigeria: one imported case. Rapid transmission has been halted in most early epicentres. More than two dozen laboratories can now test, there are close to 2,000 treatment beds, and about 3,000 people have recovered. More than 900 people are enrolled in therapeutic trials. An Ervebo trial began last month (Ervebo is not licensed for Bundibugyo virus), and two Bundibugyo-specific candidates will be added. The Director-General criticised blanket travel restrictions.

Inconsistent figures: the published WHO remarks say “more than 11 000 cases and 5400 deaths” in 67 health zones across eight provinces. CIDRAP reports the Director-General giving 11,536 confirmed cases and 5,635 confirmed deaths, figures that are not in the published text. Yesterday’s issue had ECDC 11,376 (16 Nov) and CDC via CIDRAP 11,463 cases. The Emergency Committee’s statement and any change to temporary recommendations had not been published by the cut-off. Use the WHO wording.

WHO DG remarks › · CIDRAP (discovery) ›

No new WHO Disease Outbreak News since DON627 (Switzerland chikungunya, 17 Nov; in yesterday’s issue). No ECDC Ebola daily update after 16 Nov was listed on its public health events page. PAHO’s only new outbreak-relevant item was its AMR release (04 AMR Watch). CDC, WHO AFRO and SEARO were not checked this morning.

04 AMR Watch

WHO GLASS, ECDC AMR, UKHSA, EUCAST and SAPG. World AMR Awareness Week runs 18–24 Nov.

Confirmed ECDC · Rapid risk assessment

Carbapenem-resistant Enterobacterales: fourth update of the ECDC rapid risk assessment (18 Nov)

ECDC published this update because the CRE situation in the EU/EEA is worsening and treatment options are being lost. The estimated incidence of carbapenem-resistant K. pneumoniae bloodstream infections is still rising. The CRE25 survey and EURGen-Net investigations show: a shift towards NDM carbapenemases in K. pneumoniae; increasing acquisition of yersiniabactin and aerobactin, which may favour prolonged colonisation, more infection and more severe disease; and wider spread of E. coli with blaOXA-244. The probability of further spread with escalating transmission is high, and the risk to patients needing healthcare is very high. Recommendations: a national CRE management team and action plan; IPC with hand hygiene prioritised alongside screening, contact precautions, communication and training; laboratory capacity for phenotypic AST and carbapenemase-gene identification so that new agents can be targeted; near-real-time WGS with metadata; stewardship and audited national treatment guidelines; access to antimicrobials effective against NDM producers; and research investment. ECDC published its 2025 EARS-Net and ESAC-Net annual epidemiological reports on the same day.

Read from the ECDC summary page only: the full PDF (fourth update) and CRE25 survey figures were not opened. No UK data are included; UK applicability is by analogy only.

ECDC rapid risk assessment › · ECDC event page ›

Confirmed PAHO · ReLAVRA+

PAHO warns of rising carbapenem resistance in the Americas (18 Nov)

Resistance to carbapenems rose in K. pneumoniae from about 15% in 2015 to 26% in 2024 (15 countries) and in E. coli from 3% to 5% (13 countries). Median carbapenem resistance in A. baumannii was 77% in 2024 (seven countries). PAHO calls for stronger surveillance, infection prevention, responsible antimicrobial use and access to new, effective antibiotics.

Regional medians: the figures come from ReLAVRA+ data reported by 15 countries (K. pneumoniae), 13 (E. coli) and 7 (A. baumannii), so they may not represent the whole region.

PAHO news release ›

EUCAST, SAPG and WHO GLASS were not checked this morning (see Gaps). The UKHSA stakeholder cascade (18 Nov) repeated ESPAUR 2025–26 and TARGET resources for World AMR Awareness Week, with nothing new.

05 IPC Watch

HIS, NHS England, UKHSA and CDC, covering healthcare-associated outbreaks, transmission incidents and IPC guidance.

Nothing new today from HIS, NHS England or CDC (not checked this morning; see Gaps). The ECDC CRE risk assessment (04 AMR Watch) contains the main IPC content in the window: hand hygiene prioritised alongside screening, contact precautions and training, and WGS to define transmission chains.

ECDC rapid risk assessment ›

06 Vaccines & Medicines

JCVI, Green Book, WHO immunisation, MHRA, FDA, EMA and NICE.

Nothing new today. There was no new JCVI statement or Green Book chapter. MHRA’s 18 Nov items were not infection-specific (the AdvanceGxP service and a regulatory sandbox call), plus a routine update to its COVID-19 test validation list. FDA, EMA and NICE were not checked this morning.

MHRA alerts ›

07 One Health

WOAH, FAO and APHA/Defra, including avian influenza and zoonoses.

Confirmed Defra/APHA · HPAI H5N1

HPAI H5N1 confirmed in commercial poultry near Coningsby, East Lindsey, Lincolnshire (AIV 2026/30) and near Thirsk, North Yorkshire (AIV 2026/31), 18 Nov

Both case notices were published on the evening of 18 Nov. Each premises has a 3 km protection zone and a 10 km surveillance zone, and all poultry will be humanely culled. Defra updated its England latest-situation page the same evening. In Northern Ireland, DAERA’s AIPZ with mandatory housing began at 00:01 on 19 Nov (announced 16 Nov after the Coagh case). Risk levels (wild birds HIGH; poultry MEDIUM where biosecurity is poor, LOW where it is good, per assessment #11) were not changed in any notice we saw.

Detail not yet published: the case notices give no flock type or size, and we did not open the declaration PDFs. Neither notice states any human exposure or UKHSA follow-up.

AIV 2026/30 › · AIV 2026/31 › · Defra latest situation ›

WOAH and FAO were not checked this morning. US dairy-herd and H9N2 items are under 09 (secondary).

08 Innovation & Technology

MHRA, FDA, FIND, and company announcements only when verified against regulators.

Nothing new today. No infection-related MHRA device or medicine authorisation was found in the window. FDA and FIND were not checked this morning.

09 Other Notable News

Short headlines with original links. CIDRAP, BMJ News and STAT are used only to find stories, which are traced to a primary page where possible.

  • Unverified CIDRAP: China has reported a new human H9N2 infection to WHO WPRO (a child in Hunan exposed to backyard poultry, recovered). It also reports, citing USDA APHIS, new H5N1 detections in dairy herds in Oklahoma and Oregon. Not traced to WHO WPRO or APHIS. CIDRAP ›
  • Unverified CIDRAP: Pennsylvania has reported another measles death. Not traced to the state health department. CIDRAP ›

BMJ News and STAT were not scanned this morning.

Continuing stories tracker

An ongoing story reappears in the daily sections only if cases, geography, risk or control measures change materially.

StoryFirst reportedToday’s statusWhat changed
UK HPAI (2026–27 season)5 Nov 2026 issue (Brigg, AIV 2026/23)YesTwo new English poultry cases: Coningsby (AIV 2026/30) and Thirsk (AIV 2026/31), 18 Nov. NI AIPZ and housing in force from 00:01 on 19 Nov.
DRC Bundibugyo EbolaOutbreak declared 15 May 2026; last newsletter lead 7 NovYesWHO DG at the third IHR EC (17 Nov): more than 11,000 cases and 5,400 deaths; 67 health zones in 8 provinces (item 3; figures inconsistent with CIDRAP’s).
Kenya and Nigeria Ebola (imported)Kenya 12 Nov issue; Nigeria OctoberNoKenya’s 42-day countdown continues (from 12 Nov).
CRE in EuropeECDC RRA third update (earlier)YesECDC fourth update (18 Nov): risk to patients very high (item 2).
UKHSA cold-health alerts11 Nov 2026 issueYesYellow alert (NW, NE, Yorkshire and the Humber) extended to 09:00 on 23 Nov.
UKHSA SFTS guidance18 Nov 2026 issueNoLinked from the SFTS overview and VHF collection pages; no UK case announced.
Bluetongue BTV-3, UK14 Nov 2026 issueNoNo update found.
UK Ebola medevac (Royal Free)7 Nov 2026 issueNoNo update found.
MERS-CoV, Qatar14 Nov 2026 issue (WHO DON626)NoNo new DON.
Clade I mpox, Europe13 Nov 2026 issue (UK overview)NoNo update found.
MenB catch-up, England13 Nov 2026 issueNoFirst doses still close on 31 Dec 2026 (UKHSA cascade reminder).
Measles, Americas11 Nov 2026 issueNoNo new PAHO release after 17 Nov; a Pennsylvania death is reported via CIDRAP only (under 09).
Chikungunya, Switzerland18 Nov 2026 issue (DON627)NoNo update.
World AMR Awareness Week / EAAD17 Nov 2026 issueYesECDC CRE RRA, PAHO carbapenem data, and the ECDC EARS-Net and ESAC-Net 2025 reports (18 Nov).

What we could not confirm

Source-access and coverage limits only. Doubts about a specific item are in a yellow note under that item.

SourceIssue
Compilation windowCut-off 06:15 Europe/London (GMT) on 19 Nov for 07:00 publication. Anything released after this is not in today’s issue.
HPAI case detailFlock type and size not stated; declaration PDFs not opened.
Ebola figuresWHO text (>11,000 / 5,400) and CIDRAP (11,536 / 5,635) differ; no ECDC update after 16 Nov; EC statement not yet published.
ECDC CRE RRAFull PDF and CRE25 figures not opened.
Not checked this morningNHS England, PHS, PHW, NI PHA, HPSC, NICE, CDC (HAN, MMWR, travel, measles), WHO AFRO and SEARO, EUCAST, SAPG, HIS, WHO GLASS, FDA, EMA, WOAH, FAO, FIND, BMJ News and STAT.
UKHSA dashboardNot opened.
Secondary onlyH9N2 (China), US dairy herds and the Pennsylvania measles death were seen via CIDRAP only.

Not out yet

  • UKHSA: week 47 flu and COVID-19 surveillance report and week 47 norovirus and rotavirus report (data to 15 Nov), announced; HNORS hospital norovirus outbreak data (resumes 26 Nov).
  • DAERA: full AIPZ and zone declarations for Northern Ireland (AIPZ in force from 00:01 on 19 Nov).
  • WHO: the statement from the third IHR Emergency Committee meeting on Bundibugyo virus disease (met 17 Nov).
  • WHO: an Ebola Disease Outbreak News after DON625 (6 Nov).
  • ECDC: next weekly Ebola update (Thursday 19 Nov).
  • Defra: an outbreak assessment covering the November UK HPAI cases.

About this issue

Audience: UK/EU clinical ID, AMS, IPC and FRCPath trainees · Window: 18 Nov 2026 05:57 GMT (previous build) → 19 Nov 2026 06:15 GMT (Wednesday → Thursday) · Compiled: 19 Nov 2026, cut-off 06:15 Europe/London (GMT), for 07:00 publication.

2
UK items written up (HPAI cases under One Health; cold-health alert)
2
New Microregistrar Moodle rows since the 18 Nov issue
2
Global or European primary-source items (WHO, ECDC); PAHO’s is under AMR
4
Items in today’s Executive Summary (UK first)
0
Infection forwards from Mail Sorter in the window
6
Coverage gaps we could not close

Counted without journals (Journal Watch owns journals). The gap count excludes the compilation-window row.

Compilation metadata, editorial rules and the source list. Doubts about a specific item are marked in a yellow note under that item.

MICROREGISTRAR · INFECTION INTELLIGENCE — Daily Infection Update for 19 November 2026. The top developments are in 01 Executive Summary, UK first; full write-ups sit in the numbered sections. Nothing has been invented, and quiet sections are left short rather than padded.

Editorial rules applied: last 24 hours prioritised · UK first · primary-source link on every item · labelled Confirmed / Investigation / Preliminary / Unverified · no recycling without a material change · no artificial quotas · a quiet section reads “Nothing new today” · Ebola may lead at most once in seven days (last led 7 Nov; item 3 today, not the lead) · no journals (Journal Watch).

Sources

What we checked for this issue, before the 06:15 cut-off on 19 Nov.

  • GOV.UK search and content APIs for UKHSA, MHRA, DHSC, Defra, APHA, VMD and JCVI (animal disease case notices, bird flu latest situation, cold-health alerts, SFTS guidance)
  • DAERA news
  • Gmail (microregistrar@gmail.com and microregistrar2021@gmail.com), searched read-only for infection updates since 18 Nov. The UKHSA stakeholder cascade (18 Nov) was read; there were no Mail Sorter forwards
  • Microregistrar MoodleCloud Google Sheet (Index tab), read through the Google connectors, with item links taken from the sheet’s embedded hyperlinks in an xlsx export
  • WHO Disease Outbreak News API; WHO speeches (Director-General’s remarks to the IHR Emergency Committee, 17 Nov, read); WHO news
  • ECDC public health events, newsroom, and the CRE rapid risk assessment summary page (fourth update)
  • PAHO news (AMR release read in full)
  • CIDRAP per-topic feeds (Ebola 64, measles 78, avian flu 49, AMS 48, influenza 69, HAI 81141, COVID-19 178636, pertussis 87, mpox 230556, C. auris 232685), used for discovery only
  • Approved but not checked this morning: NHS England, PHS, PHW, NI PHA, HPSC, NICE, CDC, WHO AFRO and SEARO, ERVISS, EUCAST, SAPG, HIS, WHO GLASS, JCVI and the Green Book (beyond GOV.UK search), FDA, EMA, WOAH, FAO, FIND, BMJ News and STAT
  • Baseline: local 2026-11-13 to 2026-11-18 issues

This summary is an AI-assisted aggregation of published sources. Always read the original article via the link before acting on anything here. For academic use only, not clinical advice.

Prepared for microregistrar.com, microregistrar.moodlecloud.com and Infection Institute.

AI-generated newsletterMICROREGISTRAR · INFECTION INTELLIGENCE — Daily Infection Update · 19 November 2026, compiled this morning (cut-off 06:15 Europe/London). Journals omitted by remit (Journal Watch). This newsletter is generated by AI. It highlights actionable, high-signal items and does not replace full guideline or primary-source review.

Prepared using LLM, Grok

Scroll to Top